2-Amino-2-(4-chloro-3-fluorophenyl)propan-1-ol, 98%, 250mg

1-Benzyl 2-(tert-butyl) hydrazine-1,2-dicarboxylate, 95.0%, 100g

(R,E)-4-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-one, 98%, 1g

2-HYDRAZINO-1-METHYLPYRIDINIUM TOSYLATE, 95.0%, 250mg

1-BROMO-2-FLUORO-2-METHYLPROPANE, 95.0%, 500mg

2-(Phenylsulfonyl)acetophenone, 99.0%, 10g

Butylchlorodihdroxytin, 98%, 500g

2,6-Dichloro-3-(trifluoromethyl)benzyl alcohol, 5g

2,2'-(Cyclohexa-2,5-diene-1,4-diylidene)dimalononitrile, 95.0%, 5g

2-(4,4-Difluorocyclohex-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

GC capillary column ROTI®Cap-1, 50 m, 0.20 mm, 0.20 µm, 1 Piece(s)

7-Fluoro-6-methoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride, 500mg

5-Bromo-2-methylpyridin-4-ol, 95.0%, 1g